A SINGLE DOSE OF MEDI-528, A MONOCLONAL ANTIBODY AGAINST INTERLEUKIN-9, IS WELL TOLERATED IN MILD AND MODERATE ASTHMATICS IN THE PHASE II TRIAL MI-CP-138 Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- October 2007
has subject area
- 1103 Clinical Sciences (FoR)
- Respiratory System (Science Metrix)
published in
- Chest Journal
presented at event
- CHEST 2007 Conference Conference